[{"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0821-2019", "product_description": "Dr. King's SafeCare Rx Obsessions/Compulsions, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955183020, NDC 57955-1831-2", "product_quantity": "186 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060116F Exp. 06/19; 020917F Exp. 02/20"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1211-2020", "product_description": "Hydrocortisone 2.5%/Econazole 1% 50/50 Using Powder 25%/1% Cream 60 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45212 Discard by: 9/9/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88591", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0827-2021", "product_description": "Arformoterol Tartrate Inhalation Solution 15 mcg*/2 mL For Oral Inhalation Only Rx Only Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 a) 60x2 mL Sterile Unit-Dose Vials NDC 68462-833-65; b) 30x2 mL Sterile Unit-Dose Vials NDC 68462-833-35", "product_quantity": "a) 5362 inhalers; b) 5593 inhalers", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210827", "center_classification_date": "20210921", "termination_date": "20231004", "report_date": "20210929", "code_info": "Lots: a) 30210041 Exp. 03/31/2023; 30210045 Exp. 04/30/2023; 30210046 Exp. 04/30/2023; 30210050 Exp. 03/31/2023; 30210051 Exp. 04/30/2023; 30210058 Exp. 04/30/2023; b) 30210042 Exp. 03/31/2023; 30210047 Exp. 04/30/2023; 30210048 Exp. 04/30/2023; 30210052 Exp. 04/30/2023; 30210053 Exp. 04/30/2023; 30210054 Exp. 04/30/2023; 30210059 Exp. 04/30/2023; 30210060 Exp. 04/30/2023; 30210061 Exp. 04/30/2023; 30210062 Exp. 04/30/2023; 30210063 Exp. 04/30/2023; 30210064 Exp. 05/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1753-2019", "product_description": "BLEOMYCIN 18 UNITS / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0274-2020", "product_description": "S-MIC/B12(C)/CARNITINE 25/50/50/1/50MG/ML MDV INJ;           Lot #:   S07172019DT@10, Exp 1/17/20;  S02142019DH@01, Exp 8/14/19; S03192019DT@04,Exp 9/19/19; \" S04162019DT@15, Exp 10/16/19; S07232019DH@04, Exp 1/23/20; S02142019DH@01, Exp 8/14/19; S04162019DT@15, Exp 9/9/19; s07092019dt@19, Exp 8/9/19; S07292019DH@09, Exp 8/29/19;  S02192019DH@10, Exp 8/19/19; S03302019DT@02, Exp 9/30/19;  S05062019DH@12, Exp 11/6/19; S06162019DH@13, Exp 12/16/19; S07102019DT@16, Exp 1/10/20; S07132019DT@05, Exp 1/13/20; S01302019DT@08, Exp 8/30/19; S03072019DH@01, Exp 9/7/19; S02192019DH@12, Exp 8/19/19; S03072019DH@02, Exp 9/7/19; S03272019DT@04, Exp 9/27/19; S04172019DT@03, Exp 10/17/19; S04302019DT@11, Exp 10/30/19; S05162019DH@20, Exp 11/16/19; S05292019DT@03, Exp 11/29/19; S06252019DH@17, Exp 12/25/19; S07172019DT@12, Exp 1/17/20; S07182019DT@08, Exp 1/18/20; S05242019DT@10, Exp 11/24/19         Red Mountain Compounding RX", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S07022019DT@09, Exp 10/2/19; S05082019DT@08, Exp 8/8/19; S06042019DT@07, Exp 9/4/19"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "61917", "recalling_firm": "Linde Gas LLC", "address_1": "7029 Huntley Rd Ste K", "address_2": "N/A", "postal_code": "43229-1059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Distributed only within Ohio.  No Federal Government, foreign or Canadian consignees received product.", "recall_number": "D-1383-2012", "product_description": "LifeGas OXYGEN COMPRESSED UN1072 USP,   Distributed by: Linde", "product_quantity": "283 cylinders", "reason_for_recall": "CGMP Deviations: The pressure gages, vacuum gages, and thermometer had surpassed the calibration expiry period, which may have resulted in overfill/underfill of oxygen cylinders.", "recall_initiation_date": "20120504", "center_classification_date": "20120615", "termination_date": "20130611", "report_date": "20120627", "code_info": "LOT#: 117H201  LOT#: 117H202"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg may be potentially mislabeled as    CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: W003788, EXP: 6/27/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W003870, EXP: 6/27/2014.", "address_2": "", "product_quantity": "210 Capsules", "code_info": "OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg has the following codes    Pedigree: W003789, EXP: 6/27/2014;  Pedigree: W003873, EXP: 6/27/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 11523726503", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-501-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206917"], "brand_name": ["LINEZOLID"], "generic_name": ["LINEZOLID"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-242"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LINEZOLID"], "rxcui": ["1662285"], "spl_id": ["dd9cd434-03f1-4f0d-ad84-c5611f6e5abf"], "spl_set_id": ["b721756c-3b5e-456d-a2f6-0d8a56cc7f35"], "package_ndc": ["55150-242-51"], "is_original_packager": [true], "nui": ["N0000175495", "M0361132"], "pharm_class_epc": ["Oxazolidinone Antibacterial [EPC]"], "pharm_class_cs": ["Oxazolidinones [CS]"], "unii": ["ISQ9I6J12J"]}, "product_type": "Drugs", "event_id": "79772", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0703-2018", "product_description": "Linezolid Injection 600 mg per 300 mL (2 mg/mL) For Intravenous Administration, Rx only, Manufactured By: Aurobindo Pharma Limited IDA Pashamylaram - 502307, India, Manufactured for AuroMedics Pharma, LLC, NDC 55150-242-51", "product_quantity": "395150 bags", "reason_for_recall": "Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap", "recall_initiation_date": "20180327", "center_classification_date": "20180503", "termination_date": "20220218", "report_date": "20180509", "code_info": "Lot/Batch #'s:    CLZ160001, CLZ160002, CLZ160003, CLZ160004 exp July 2018;     CLZ160005, CLZ160006, CLZ160008, CLZ160009, CLZ160010 and CLZ160012, exp August 2018;     CLZ160013, CLZ160014, CLZ160015, CLZ160016, exp October 2018;     CLZ160017, CLZ160018, CLZ160019, CLZ160021, CLZ160022, CLZ160023, exp November 2018;    CLZ170001, CLZ170002, CLZ170003, CLZ170004, CLZ170005, CLZ170006, exp March 2019;     CLZ170007, CLZ170008, CLZ170009, CLZ170010, exp May 2019;    CLZ170011, CLZ170012, exp June 2019;    CLZ170013, CLZ170014, CLZ170015, CLZ170016, exp, September 2019;    CLZ170017, exp October 2019"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0581-2023", "product_description": "Ampicillin for Injection, USP 500 mg per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-221-41", "product_quantity": "17,350 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-1013-2013", "product_description": "ASCORBIC ACID (CORN SOURCE) 500 MG/ML INJECTABLE, all configurations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "02202013@9 and 04052013@2", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA086242"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-447"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["905199"], "spl_id": ["13a2cf75-5816-2d86-e063-6394a90a0cc2"], "spl_set_id": ["53908945-540f-4d34-8f0a-b4a87676634e"], "package_ndc": ["68084-447-11", "68084-447-01"], "original_packager_product_ndc": ["23155-001"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "93936", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0320-2024", "product_description": "HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC Carton: 68084-447-01;  NDC Unit Dose: 68084-447-11", "product_quantity": "2,850 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.", "recall_initiation_date": "20240201", "center_classification_date": "20240208", "report_date": "20240214", "code_info": "Lot #: 1012275, Exp 02/28/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0311-2022", "product_description": "EPINEPHrine in 0.9% Sodium Chloride Injection, 16 mg per 250 mL (64 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-627-01.", "product_quantity": "684 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21335/BZV", "more_code_info": ""}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0988-2017", "product_description": "Potassium PHOSphate in 0.9% Sodium Chloride Injection 20 mMol in 100 mL in 150 mL Intravia Bag, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5287 NDC# 61553-287-48", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lot: 171320001D, 8/10/2017"}, {"status": "Terminated", "city": "Toronto", "state": "N/A", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71046", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1079-2015", "product_description": "Olanzapine, Orally Disintegrating Tablets, 5 mg, a) 30-count bottle (NDC 60505-3275-03), b) 100-count blister (NDC 60505-3275-00), Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9", "product_quantity": "23,274 bottles/ blister cartons", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20150407", "center_classification_date": "20150514", "termination_date": "20170407", "report_date": "20150520", "code_info": "Lot #: a) KL0655, Exp 04/15; KY2374, Exp 05/16; b) KL0656, Exp 04/15; KY2371, Exp 05/16", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-1009-2013", "product_description": "VITAMIN B-COMPLEX INJECTABLE, VITAMIN B-COMPLEX SL SOLN and VITAMIN B-COMPLEX (PF) INJECTABLE, all configurations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "07022013@37, 01152013@32, 03012013@22, 03062013@15, 03122013@14, 04102013@4, 04242013@14, 04302013@2, 05242013@9, 06122013@26, 06122013@20, 07112013@16, 07232013@2", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0751-2023", "product_description": "Sodium Phosphates Injection 4 mEq/3 mMol/mL, 500 ml bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-8077-1, code 7128580771.", "product_quantity": "3165 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883239, 37-883240, Exp 05/01/2023; 37-884419, 37-884423, Exp 05/04/2023; 37-889009, Exp 05/23/2023; 37-890261, 37-890262, Exp 05/29/2023; 37-891250, Exp 05/31/2023; 37-891412, Exp 06/01/2023; 37-895488, Exp 06/19/2023; 37-896456, Exp 06/21/2023; 37-898159, Exp 06/28/2023"}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-0999-2015", "product_description": "HCG 1000 Units/mL Injection, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74874", "recalling_firm": "Pharmatech LLC", "address_1": "4131 Sw 47th Ave", "address_2": "Suite 1403", "postal_code": "33314-4026", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1526-2016", "product_description": "Senna Syrup (sennosides) 8.8 mg, 8 fl. oz. (237 mL) bottle, Distributed by: Major Pharmaceuticals, 31778 Enterprise Drive, Livonia, MI  48150, NDC 0904-6289-09.", "product_quantity": "68,908 bottles", "reason_for_recall": "CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.", "recall_initiation_date": "20160808", "center_classification_date": "20160927", "termination_date": "20240923", "report_date": "20161005", "code_info": "Lot #: 20391517, Exp 09/17; 20391518, Exp10/17; 20391519, Exp 11/17; 20391601, Exp 01/18; 20391602, Exp 02/18; 20391604, 20391605, Exp 03/18; 20391608, Exp 06/18"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69359", "recalling_firm": "Valeant Pharmaceuticals International", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0025-2015", "product_description": "Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for:  Rouses Point Pharmaceuticals, LLC Cranford, NJ 07016 By:  Ferndale Laboratories, Inc. Ferndale, MI  48220 --- NDC 43478-270-15", "product_quantity": "34,218 tubes", "reason_for_recall": "Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point", "recall_initiation_date": "20141002", "center_classification_date": "20141016", "termination_date": "20150403", "report_date": "20141022", "code_info": "Lot numbers 13052C, exp 03/2015 and 13156A, exp 08/2015, NDC 43478-270-15"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1217-2019", "product_description": "NICARdipine 25 mg in NS 250 mL EXCEL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "1783 bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: EA161909 Exp. 4/16/2019; EA211907 Exp. 4/21/2019; EB041906 Exp. 5/5/2019; EB111908 Exp. 5/12/2019; EB181907 Exp. 5/19/2019; EB251910 Exp. 5/26/2019; EC111908 Exp. 6/9/2019; EC201909 Exp. 6/18/2019; EC261909 Exp. 6/24/2019; EC271919 Exp. 6/25/2019"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0195-2022", "product_description": "TRI-MIX PAPAVERINE 25/PHENTOLAMINE 3/PGE-1 80 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08042021:05 BUD: 11/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Ringwood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80196", "recalling_firm": "Inopak Ltd", "address_1": "24 Executive Pkwy", "address_2": "N/A", "postal_code": "07456-1430", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0864-2018", "product_description": "Option Systems Antibacterial Foaming Hand Wash with .3% PCMX, 1000 mL pouches, Inopak, LTD, Ringwood, NJ", "product_quantity": "1345 cases", "reason_for_recall": "Microbial contamination of NonSterile Product; FDA analysis returned out of specification results for total aerobic microbial counts", "recall_initiation_date": "20180516", "center_classification_date": "20180613", "termination_date": "20201023", "report_date": "20180620", "code_info": "7302 01 039, 7302 03 039, 7302 01 040 and 7302 01 043"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0519-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-17", "product_quantity": "2,352 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2400679, Exp Date: 02/28/2026"}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76664", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0632-2017", "product_description": "Adalat CC (nifedipine) Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 50419-70305", "product_quantity": "N/A", "reason_for_recall": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib", "recall_initiation_date": "20170307", "center_classification_date": "20170404", "termination_date": "20171215", "report_date": "20170412", "code_info": "Lot #: BXH66D1A, Exp. 03/2018"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "B0105 Exp 8/19/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Doxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-725-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Ongoing", "city": "Santa Ana", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93616", "recalling_firm": "Private Label Partners, Inc.", "address_1": "551 N Fairview St", "address_2": "N/A", "postal_code": "92703-1806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ", "recall_number": "D-0152-2024", "product_description": "Selenium Sulfide 2.25% Shampoo, 180mL bottle, Rx Only, Manufactured for: Bi-Coastal Pharma Int. LLC, Shrewsbury, NJ 07702, NDC 42582-900-06.", "product_quantity": "3,396 bottles", "reason_for_recall": "CGMP Deviations: Stability data does not support expiry date.", "recall_initiation_date": "20231213", "center_classification_date": "20231219", "report_date": "20231227", "code_info": "Lot #220551, Exp: 2/28/2025"}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103976"], "brand_name": ["XOLAIR"], "generic_name": ["OMALIZUMAB"], "manufacturer_name": ["Genentech, Inc."], "product_ndc": ["50242-040", "50242-214", "50242-215", "50242-227"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["OMALIZUMAB"], "rxcui": ["1657209", "1657212", "2058943", "2058946", "2058949", "2058950", "2663917", "2663918", "2663920", "2663923", "2673760", "2673761", "2673762", "2673763"], "spl_id": ["0c18e533-1b61-4224-9e5c-05cd1eb86f2b"], "spl_set_id": ["7f6a2191-adfb-48b9-9bfa-0d9920479f0d"], "package_ndc": ["50242-040-62", "50242-040-86", "50242-214-01", "50242-214-86", "50242-214-03", "50242-214-55", "50242-214-99", "50242-214-83", "50242-215-86", "50242-215-01", "50242-215-03", "50242-215-55", "50242-215-99", "50242-215-83", "50242-227-01", "50242-227-55", "50242-227-99", "50242-227-86"], "is_original_packager": [true], "nui": ["N0000175794", "N0000175793", "N0000175792"], "pharm_class_epc": ["Anti-IgE [EPC]"], "pharm_class_pe": ["Decreased IgE Activity [PE]"], "pharm_class_moa": ["IgE-directed Antibody Interactions [MoA]"], "unii": ["2P471X1Z11"]}, "product_type": "Drugs", "event_id": "97360", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide Within the U.S.", "recall_number": "D-0572-2025", "product_description": "Xolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc., South San Francisco, CA 94080, NDC 50242-214-55", "product_quantity": "4 units", "reason_for_recall": "CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.", "recall_initiation_date": "20250730", "center_classification_date": "20250807", "report_date": "20250813", "code_info": "Lot: 3630004, Expires: 10/31/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075866"], "brand_name": ["PORTIA"], "generic_name": ["LEVONORGESTREL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9020"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238019", "748797", "748878", "751890"], "spl_id": ["4d63fa4a-ff46-4f2e-b9d5-cab4f5fe1d85"], "spl_set_id": ["c78b236b-85c4-4258-a524-cea08775100c"], "package_ndc": ["0555-9020-79", "0555-9020-58"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "64607", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-245-2013", "product_description": "Portia (levonorgestrel and ethinyl estradiol) Tablets, USP, 0.15 mg/0.03 mg, 28-count tablets (containing 21 pink tablets followed by 7 white tablets) per blister card packaged in 6 blister cards per carton, Rx only, Barr Laboratories, Inc., Pomona, NY  10970, NDC 0555-9020-58.", "product_quantity": "17,661 blister cards", "reason_for_recall": "Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.", "recall_initiation_date": "20130312", "center_classification_date": "20130410", "termination_date": "20140115", "report_date": "20130417", "code_info": "Lot #: 33801951A, and 33802189A, Exp 03/13", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202719"], "brand_name": ["BIMATOPROST"], "generic_name": ["BIMATOPROST"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-6206"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BIMATOPROST"], "rxcui": ["1041495"], "spl_id": ["4bc9d5b3-468b-48d7-b0dd-5b0498d01bce"], "spl_set_id": ["27bef7e1-750a-4ac1-ab5f-e4c0121ffcbc"], "package_ndc": ["0781-6206-75", "0781-6206-93"], "is_original_packager": [true], "nui": ["N0000175454", "M0017805"], "pharm_class_epc": ["Prostaglandin Analog [EPC]"], "pharm_class_cs": ["Prostaglandins [CS]"], "unii": ["QXS94885MZ"]}, "product_type": "Drugs", "event_id": "84082", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0161-2020", "product_description": "Bimatoprost Ophthalmic Solution 0.03%, Rx Only, For Topical Application to the Upper Eyelid, Sterile, a) 3 mL bottle NDC 0781-6206-93, b) 5 mL bottle NDC 0781-6206-75, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc., Princeton, NJ 08540, Product of Argentina.", "product_quantity": "346,929 bottles", "reason_for_recall": "Labeling: Incorrect or missing package insert.", "recall_initiation_date": "20191017", "center_classification_date": "20191028", "termination_date": "20220119", "report_date": "20191106", "code_info": "Lot #s: a) 290635FA, 290635FB, Exp. 11/30/2019; 293230F, Exp. 6/30/2020; 294628F, 301337F, Exp. 11/30/2020; 304451FA, Exp. 1/31/2021.    b) 290636FA, 290636FB, 290636FC, Exp. 11/30/2019; 293233FA, 293233FB, Exp. 5/31/2020; 293234FA, 293234FB, Exp. 6/30/2020; 294630F, 301338FA, 301338FB, 309426F, Exp. 11/30/2020; 304455FA, 304455FB Exp. 2/28/2021; 304883F, Exp. 4/30/2021; 312790F, Exp. 5/31/2021.", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0314-2017", "product_description": "TriMix, Alprostadil/Phentolamine/Papaverine 20mcg/0.5mg/30mg/mL, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "8 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06012016E (07/16/2016), 09272016B (11/06/2016), 10032016G (11/14/2016), 11012016D (12/09/2016)."}, {"status": "Terminated", "city": "Temple Terrace", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91283", "recalling_firm": "BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy", "address_1": "7802 E Telecom Pkwy", "address_2": "N/A", "postal_code": "33637-0928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "BayCare Health System hospitals in FL", "recall_number": "D-0086-2023", "product_description": "Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count syringes packaged in a bag labeled as Omnipaque (iohexol) 300 mg I/mL, 2.4g Iodine/8 mL in a 10 mL syringe, Compounded with GE Healthcare product, Each mL contains (647 mg) of iohexol as 300 mg of organically bound iodine, 1.21 mg tromethamine, and 0.1 mg edetate calcium disodium, For Injection or oral use; Rx Only, BayCare Central Pharmacy, 7802 Telecom Parkway, Temple Terrace, FL 33637.", "product_quantity": "250 syringes", "reason_for_recall": "Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL", "recall_initiation_date": "20221201", "center_classification_date": "20221222", "termination_date": "20240315", "report_date": "20221221", "code_info": "Lot: IOHE2.420221128, Exp. 12/7/2022"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81684", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0348-2019", "product_description": "NYSTATIN Oral Suspension, USP 500,000 Units/5mL, unit dose 5ml cups, packaged in a) 50 unit dose cups (10x5ml unit dose cups per tray, 5 trays per case) NDC 66689-037-50; b) 100 unit dose cups (10x5ml unit dose cups per tray, 10 trays per case) NDC 66689-037-99. Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771", "product_quantity": "4,065,550 5 ml cups", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification for impurities.", "recall_initiation_date": "20181130", "center_classification_date": "20190107", "termination_date": "20201125", "report_date": "20181226", "code_info": "Lots:   a) 505300 Exp. Dec 2018; 522200 Exp. Apr 2019; 534400 Exp. Jul 2019;  539000 Exp. Aug 2019; 543400 Exp. Sep 2019;   b) 523600, 522200X Exp. Apr 2019; 535500 Exp. Jul 2019; 540700 Exp. Aug 2019; 543300 Exp. Sep 2019; 550100 Exp. Oct 2019.", "more_code_info": ""}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "20 mL in Vials", "code_info": "a) Lot #: 160222-85, BUD: 07/05/16.  b) Lot #: 160222-85, BUD: 07/05/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "METHYL B12 1000MCG/ML/PYRIDOXINE 100MG  W/PRES. (BENZALKONIUM 0.01%), In a) 1ML Vials and b) 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1215-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Vitamin D (Ergocalciferol) 800 u/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1142-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65629", "recalling_firm": "Max Huber Research Labs, Inc.", "address_1": "767 Fifth Avenue", "address_2": "N/A", "postal_code": "10153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-816-2013", "product_description": "LA MER the spf 18 fluid tint , broad spectrum spf 18, 1.7 fl.oz. liq./50 ml, Shade DARK 04, UPC 7 47930 00483 7 --- MAX HUBER RESEARCH LABS INC., DIST. NEW YORK, N.Y. 10022 -- MADE IN BELGIUM", "product_quantity": "49,845 tubes (total for all products)", "reason_for_recall": "Subpotent drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled", "recall_initiation_date": "20130627", "center_classification_date": "20130722", "termination_date": "20180518", "report_date": "20130731", "code_info": "all lots currently in the market shipped before June 2013", "more_code_info": ""}, {"status": "Terminated", "city": "Coyotepec", "state": "", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86063", "recalling_firm": "Maquiladora Miniara Sa De Cv", "address_1": "Crta. Teoloyucan Huehuetoca Km. 22", "address_2": "Coyotepec", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1565-2020", "product_description": "Shine & Clean Hand Sanitizer gel, (Ethyl Alcohol 70%), 33.81 fl oz (1L) bottle, Made in Mexico By: Maquiladora Miniara S.A. de C.V. Carrerera Teoloyucan Huehuetoca km: 22 S/N La Planada Mexico C.P.: 54665 NDC 76753-001-01", "product_quantity": "245,500 bottles", "reason_for_recall": "CGMP Deviations: Products manufactured at the same site were FDA testing found below the label claim for ethanol content and the presence of undeclared methanol.", "recall_initiation_date": "20200709", "center_classification_date": "20200910", "termination_date": "20240424", "report_date": "20200916", "code_info": "Lots: F200829088, F200829095, F200829107, D202728743, D202528742, D202428733, D202728743, D2028753, D202528742, D202428733, D202028689, D201828660, D202428734, E200128784, E200418795,   D202428734, D202828689, D201828660, E201628912, E201628913, E201628911, E201528902, E201528903, E201628910, E201628918, E201628914, E201628915, E201628916, E201628917, E202328969, E202428975, E202528981, E202128947, E201728918, E201728919, E201428876,  E201828894, E201828920, E201428876, E201128850, E201328859, E200628817, E200828826, E200928840, D202128699, D202428700.", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-271-2014", "product_description": "Sodium Tetradecyl Sulfate 3.0%, 30ml Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019635"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-5802", "0264-5804"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807552", "1807634", "1807639"], "spl_id": ["d34ea9bc-a1f9-402a-97cf-894505cee75d"], "spl_set_id": ["e44c41ae-c9c8-4dd8-ba6c-cebb585378aa"], "package_ndc": ["0264-5802-00", "0264-5802-10", "0264-5804-00", "0061858305", "0061858306"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "92640", "recalling_firm": "B. Braun Medical Inc.", "address_1": "1845 Mason Ave", "address_2": "N/A", "postal_code": "32117-5102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0916-2023", "product_description": "0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medical Inc. Bethlehem, PA 18018-3524 USA, NDC 0264-5802-00", "product_quantity": "79,880 bags", "reason_for_recall": "Lack of assurance of sterility: bags have the potential to leak.", "recall_initiation_date": "20230705", "center_classification_date": "20230713", "termination_date": "20240423", "report_date": "20230719", "code_info": "Lot#: 0061858305, 0061858306 Exp 3/31/2025", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: REPAGLINIDE, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs:  VALSARTAN, Tablet, 40 mg, NDC 00078042315, Pedigree: AD52372_1, EXP: 5/17/2014;  GUAIFENESIN, Tablet, 200 mg, NDC 00904515460, Pedigree: W002853, EXP: 6/7/2014;  MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68585000575, Pedigree: W003923, EXP: 6/28/2014.", "address_2": "", "product_quantity": "500 Tablets", "code_info": "REPAGLINIDE, Tablet, 1 mg has the following codes:   Pedigree: AD52387_1, EXP: 5/17/2014;  Pedigree: W002855, EXP: 6/7/2014;  Pedigree: W003924, EXP: 6/28/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "REPAGLINIDE, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00169008281.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-868-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1081-2018", "product_description": "DMSO 6.25% Opth Sol, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA  15644.", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"country": "United States", "city": "Lake Forest", "address_1": "275 N Field Dr", "reason_for_recall": "Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.", "address_2": "", "product_quantity": "74,256 units", "code_info": "Lot #: 11-161-JT, Exp 11/13", "center_classification_date": "20130621", "distribution_pattern": "Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia", "state": "IL", "product_description": "5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL VisIV Container, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7926-48", "report_date": "20130703", "classification": "Class II", "openfda": {}, "recalling_firm": "Hospira Inc.", "recall_number": "D-615-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61918", "termination_date": "20150717", "more_code_info": "", "recall_initiation_date": "20120504", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; DESIPRAMINE HCL Tablet, 50 mg may be potentially mislabeled as    clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: AD30140_4, EXP: 5/7/2014.", "address_2": "", "product_quantity": "98 Tablets", "code_info": "DESIPRAMINE HCL, Tablet, 50 mg has the following code    Pedigree: AD30140_7, EXP: 5/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DESIPRAMINE HCL Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 45963034302", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-571-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0994-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 5% with CALCIUM and HEPARIN, total volume = 250mL, IV Bag, Rx Only, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0415-1", "product_quantity": "68 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251453, Exp. 7/14/2023; 36-252361, Exp. 7/17/2023."}, {"status": "Terminated", "city": "Riverside", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "64571", "recalling_firm": "Green Planet Inc", "address_1": "7260 Sycamore Canyon Blvd", "address_2": "N/A", "postal_code": "92508-2332", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-828-2013", "product_description": "Night Bullet Capsules, supplied in 1 count packets, produced by Green Planet Inc, Riverside, CA", "product_quantity": "429,619 capsules", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; product contains analogues of sildenafil and tadalafil which are active pharmaceutical ingredients in FDA-approved drugs used to treat erectile dysfunction (ED) making this product an unapproved new drug.", "recall_initiation_date": "20130311", "center_classification_date": "20130729", "termination_date": "20130816", "report_date": "20130807", "code_info": "Lot# B43N032, Exp 10/15", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1038-2022", "product_description": "Glucagen (glucagon) for injection, packaged in a 10-count box, (10 vials each containing 1 mg per vial), Rx only, MFG: Boehringer Mannheim, NDC 0597-0053-45", "product_quantity": "1 carton/10 vials per carton", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0746-2018", "product_description": "Enbrel PFS 50 mg/mL Inj #4 NDC 58406-0435-04 28 days supply;", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1479-2022", "product_description": "Magnesium Hydroxide 2400 mg, Aluminum Hydroxide 2400 mg, Simethicone 240 mg MAX, per 30 mL Oral Suspension, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-6839-73", "product_quantity": "43,200 cups", "reason_for_recall": "Microbial Contamination of Non-Sterile Products.", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot #: 20051A, EXP Aug. 2022; 20088A, EXP Sep. 2022."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-557-2015", "product_description": "Calcium Sulfate Hemihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0264-2020", "product_description": "S-FOLIC ACID 20MG/ML MDV INJ, packaged in a)10ml b) 30ml, glass vials, Rx Only, Red Mountain Compounding Rx.", "product_quantity": "1x10, 1x30 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot#  S05162019DH@17, Exp 8/26/19; S07262019DH@08, Exp 10/26/19"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0727-2019", "product_description": "Dr. King's SafeCare Rx Asthma Clear Allergy, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955004424, NDC 57955-0044-2", "product_quantity": "797 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 012116S Exp. 01/19; 122116A Exp. 12/19"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79060", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd Nw", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0338-2018", "product_description": "Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist. By McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51", "product_quantity": "24120 cups", "reason_for_recall": "Subpotent Drug: Out of specification for assay (stability testing)", "recall_initiation_date": "20180129", "center_classification_date": "20180208", "termination_date": "20201124", "report_date": "20180214", "code_info": "Lot #: 0114588, Exp 10/18"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091024"], "brand_name": ["ESZOPICLONE"], "generic_name": ["ESZOPICLONE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-617", "55111-629", "55111-619"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESZOPICLONE"], "rxcui": ["485440", "485442", "485465"], "spl_id": ["bf1433f5-bde8-8c67-9ff7-ec5d3ed26581"], "spl_set_id": ["0b363b90-93dc-1fc1-0501-d140dfc762c7"], "package_ndc": ["55111-629-30", "55111-629-01", "55111-629-05", "55111-619-30", "55111-619-90", "55111-619-01", "55111-619-05", "55111-619-79", "55111-619-09", "55111-617-30", "55111-617-90", "55111-617-01", "55111-617-05", "55111-617-79", "55111-617-09"], "is_original_packager": [true], "upc": ["0355111617013", "0355111629306", "0355111619017"], "unii": ["UZX80K71OE"]}, "product_type": "Drugs", "event_id": "94754", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "OH, MS", "recall_number": "D-0581-2024", "product_description": "Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30", "product_quantity": "13,752 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Related Substances", "recall_initiation_date": "20240604", "center_classification_date": "20240702", "report_date": "20240710", "code_info": "Lot#: C2302598, Exp 2/29/2025"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and  one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.", "address_2": "Suite 180", "product_quantity": "1395 Vials total; 900x1 ml vials 20121105-B; 90x 2ml vials of lot 20121112-G and 495x1 ml vials of lot 20121112-G.", "code_info": "Lot #s: 20121105-B, 20121112-G", "center_classification_date": "20130515", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Methylprednisolone Preservative Free 40 mg/ml Injectible Suspension, 1 mL Vials and 2 mL Vials and 1 mL pre-filled syringes, For Office Use Only, Manufactured by Green Valley Drugs, Henderson, NV.", "report_date": "20130522", "classification": "Class I", "openfda": {}, "recalling_firm": "Green Valley Drugs", "recall_number": "D-321-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63953", "termination_date": "20130517", "more_code_info": "", "recall_initiation_date": "20121204", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA065498"], "brand_name": ["PIPERACILLIN AND TAZOBACTAM"], "generic_name": ["PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-119", "55150-120", "55150-121"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PIPERACILLIN SODIUM", "TAZOBACTAM SODIUM"], "rxcui": ["1659131", "1659137", "1659149"], "spl_id": ["a14027c8-ca29-4846-b798-6970a3239ca8"], "spl_set_id": ["39e19789-de4b-4fd1-ab1c-92f59496f496"], "package_ndc": ["55150-119-30", "55150-120-30", "55150-121-50"], "is_original_packager": [true], "upc": ["0355150119301", "0355150120307", "0355150121502"], "unii": ["M98T69Q7HP", "UXA545ABTT"]}, "product_type": "Drugs", "event_id": "79995", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0926-2018", "product_description": "Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ 05610. NDC 55150-120-30", "product_quantity": "77,400 vials", "reason_for_recall": "Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass", "recall_initiation_date": "20180501", "center_classification_date": "20180717", "termination_date": "20230621", "report_date": "20180523", "code_info": "Lot #s: PP0317061-A, PP0317049-A; EXP August 2019", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20171017@87, BUD 04/15/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Estradiol 40 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0679-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0119-2016", "product_description": "PYRIDOXINE HCL, injectable Solution, 100 mg/mL, 30mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "6 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t05292015@5"}, {"status": "Terminated", "city": "Ringwood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82645", "recalling_firm": "Inopak Ltd", "address_1": "24 Executive Pkwy", "address_2": "N/A", "postal_code": "07456-1430", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1311-2019", "product_description": "AQUACIL instant foaming hand sanitizer, alcohol free formula, benzalkonium chloride 0.1% (w/w), packaged in a) 18 FL OZ (532 mL) bottles, 12/18OZ bottles per case, Product Code BIO-5075-432-02; b) 1000 ML pouches, 6/1000 ML pouches per case, Product Code BIO575-OS1000, Biocentris Pharmaceuticals (Division of Inopak).", "product_quantity": "17,850 pounds per batch", "reason_for_recall": "CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.", "recall_initiation_date": "20190422", "center_classification_date": "20190529", "termination_date": "20240828", "report_date": "20190605", "code_info": "Batch #: 6736, 6826"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0106-2016", "product_description": "METHYLCOBALAMIN MDV, Injectable Solution, 2 MG/ML, 10mL syringe; Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t06042015@22, t01202015@4, t05082015@5"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1276-2015", "product_description": "Captopril Tablets, USP, 50 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0904-01) and B) 1000 Count Bottles (NDC: 64679-0904-02), Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.", "product_quantity": "A) 216,329 Bottles and B) 18,514 Bottles.", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "A) Lot #: LM11093, Expiry: 6/30/2015; Lot #: LM11335, Expiry: 7/31/2015; Lot #: LM11336, Expiry: 7/31/2015; Lot #: LM11461, Expiry: 8/31/2015; Lot #: LM11462, Expiry: 8/31/2015; Lot #: LM11579, Expiry: 8/31/2015; Lot #: LM11778, Expiry: 9/30/2015; Lot #: LM11995, Expiry: 11/30/2015; Lot #: LN10029, Expiry: 11/30/2015; Lot #: LN10071, Expiry: 12/31/2015; Lot #: LN10349, Expiry: 1/31/2016; Lot #: LN10350, Expiry: 1/31/2016; Lot #: LN10505, Expiry: 2/29/2016; Lot #: LN10506, Expiry: 2/29/2016; Lot #: LN10814, Expiry: 3/31/2016; Lot #: LN10815, Expiry: 3/31/2016; Lot #: LN10977, Expiry: 4/30/2016; Lot #: LN11156, Expiry: 6/30/2016; Lot #: LN11260, Expiry: 7/31/2016.  B) Lot #: LM10643, Expiry: 4/30/2015; Lot #: LM10846, Expiry: 5/31/2015; Lot #: LM11347, Expiry: 7/31/2015; Lot #: LM11492, Expiry: 8/31/2015; Lot #: LM11493, Expiry: 8/31/2015; Lot #: LM11577, Expiry: 8/31/2015; Lot #: LM11732, Expiry: 9/30/2015; Lot #: LM11994, Expiry: 11/30/2015; Lot #: LN10072, Expiry: 12/31/2015; Lot #: LN10073, Expiry: 12/31/2015; Lot #: LN10351, Expiry: 1/31/2016; Lot #: LN10561, Expiry: 2/29/2016; Lot #: LN10562, Expiry: 2/29/2016; Lot #: LN10816, Expiry: 3/31/2016; Lot #: LN10817, Expiry: 4/30/2016; Lot #: LN11162, Expiry: 6/30/2016; Lot #: LN11170, Expiry: 6/30/2016; Lot #: LN11171, Expiry: 6/30/2016."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0137-2019", "product_description": "Arginine Injections 100 mcg/mL, Pharm D Solutions, Houston, Texas NDC 69699-1414-20", "product_quantity": "7150 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 04112018:83 Discard by: 10/8/2018; 03202018:48 Discard by: 9/16/2018; 04302018:91 Discard by: 10/27/2018"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "70 vials", "code_info": "Lot #: a) Thiamine 100 mg/30 mL: 20130130-G, Exp 4/30/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Thiamine Hydrochloride Injection, all strengths and all presentations including a) Thiamine 100 mg/30 mL, b) Thiamine Hydrochloride 100 mg/mL with preservative 30 mL, c) Thiamine Hydrochloride 50 mg/mL with preservative 30 mL, d) Thiamine Hydrochloride 100 mg/mL preservative free 10 mL and 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-414-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southborough", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67687", "recalling_firm": "New England Home Therapies, Inc", "address_1": "337 Turnpike Rd", "address_2": "N/A", "postal_code": "01772-1760", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "US: New England", "recall_number": "D-0003-2015", "product_description": "All sterile drugs compounded between 2/21/14 and 2/24/14.", "product_quantity": "87 Products", "reason_for_recall": "Lack of Assurance of Sterility: All compounded products.", "recall_initiation_date": "20140226", "center_classification_date": "20141001", "termination_date": "20160817", "report_date": "20141008", "code_info": "Expiration dates between 3/5/14 and 3/10/14."}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1811-2019", "product_description": "RomiPLOStim 700 MCG/ 1.4 ML SQ SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA065056"], "brand_name": ["AMOXICILLIN"], "generic_name": ["AMOXICILLIN"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-2263", "0093-2264", "0093-4160", "0093-4155", "0093-4161", "0093-2267", "0093-2268", "0093-3107", "0093-3109"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN"], "rxcui": ["239191", "308177", "308182", "308189", "308191", "308192", "308194", "313850", "598025"], "spl_id": ["31223839-1653-4906-826a-f9d6af179334"], "spl_set_id": ["4c0f348a-a65d-409c-8668-207c82a5e3cb"], "package_ndc": ["0093-2263-01", "0093-2264-01", "0093-4160-76", "0093-4160-78", "0093-4160-73", "0093-4155-79", "0093-4155-73", "0093-4155-80", "0093-4161-76", "0093-4161-78", "0093-4161-73", "0093-2267-01", "0093-2268-01", "0093-3107-01", "0093-3107-05", "0093-3109-53", "0093-3109-05"], "is_original_packager": [true], "upc": ["0300933107051", "0300932264014", "0300934161731", "0300933109055", "0300932267015", "0300932268012", "0300932263017", "0300934160734", "0300934155730"], "unii": ["804826J2HU"]}, "product_type": "Drugs", "event_id": "65516", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-803-2013", "product_description": "Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only,  Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960.", "product_quantity": "109,080 Bottles", "reason_for_recall": "Discoloration:  This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.", "recall_initiation_date": "20130618", "center_classification_date": "20130717", "termination_date": "20131224", "report_date": "20130724", "code_info": "Lot #s: a) 35426557A, 35426558A, Exp 08/14; b) 35426554A, 35426555A, 35426556A, Exp 08/14"}, {"status": "Terminated", "city": "Weeki Wachee", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79803", "recalling_firm": "Premier Pharmacy Labs Inc", "address_1": "8265 Commercial Way", "address_2": "N/A", "postal_code": "34613-4511", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0701-2018", "product_description": "Hydromorphone HCl 1 mg/mL PF INJ. 1mL in a 3mL Sterile Single-Dose Syringe.  8265 Commercial Way Weeki Wachee, FL 34613 NDC 69623-249-10", "product_quantity": "3570 syringes", "reason_for_recall": "Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.", "recall_initiation_date": "20180411", "center_classification_date": "20180426", "termination_date": "20200915", "report_date": "20180502", "code_info": "Lots: HYD030118IJDSA, HYD030118IJDSB, HYD030118IJDSD, HYD030118IJDSE BUD: 05/30/2018"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lot #: 5/31/17 1416 382-92425P BUD: 8/29/2017", "center_classification_date": "20170707", "distribution_pattern": "Nationwide with the United States", "state": "TX", "product_description": "Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 30 mmol in NS 250mL Bag, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404. NDC15082-924-25", "report_date": "20170719", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0955-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77595", "termination_date": "20171206", "more_code_info": "", "recall_initiation_date": "20170622", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020263"], "brand_name": ["LUPRON DEPOT-PED"], "generic_name": ["LEUPROLIDE ACETATE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-2108", "0074-2282", "0074-2440", "0074-3779", "0074-9694", "0074-3575"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "spl_id": ["ee6de7a6-05f0-42eb-a8c7-7d4fbc87674d"], "spl_set_id": ["e99f47d2-da10-3127-ecb3-e5d942ae6e81"], "package_ndc": ["0074-2108-03", "0074-2282-03", "0074-2440-03", "0074-3779-03", "0074-9694-03", "0074-3575-01", "0074-3410-01", "0074-0010-01"], "is_original_packager": [true], "upc": ["300743779035"]}, "product_type": "Drugs", "event_id": "67709", "recalling_firm": "AbbVie Inc", "address_1": "1 N Waukegan Rd", "address_2": "", "postal_code": "60064", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1289-2014", "product_description": "LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 11.25 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL  60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3779-03, UPC 3 00743 77903 5.", "product_quantity": "12 kits", "reason_for_recall": "Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.", "recall_initiation_date": "20140310", "center_classification_date": "20140429", "termination_date": "20160622", "report_date": "20140507", "code_info": "Lot #:1013566, Exp 12/08/16", "more_code_info": ""}, {"status": "Terminated", "city": "Beloeil", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84055", "recalling_firm": "8046255 Canada Inc. DBA Viatrexx", "address_1": "1360 Louis-Marchand St", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to physicians Nationwide throughout the United States and Puerto Rico.", "recall_number": "D-0342-2020", "product_description": "Viatrexx-Relief +, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0615, NDC 73069-450-41.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.", "recall_initiation_date": "20191015", "center_classification_date": "20191114", "termination_date": "20201210", "report_date": "20191120", "code_info": "Lot Numbers: 19-S00024, Exp. May: 2020"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0769-2019", "product_description": "Dr. King's SafeCare Rx Nosebleed Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955014027, NDC 57955-0140-2", "product_quantity": "35 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 051716K Exp. 05/19; 030317A Exp. 03/20"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84620", "recalling_firm": "Idelle Labs", "address_1": "One Helen Of Troy Plaza", "address_2": "N/A", "postal_code": "79912", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0784-2020", "product_description": "SURE 48hr Confidence Nourishing Coconut invisible solid Antiperspirant & Deodorant Net Wt 2.6 oz (73g) NDC# 41595-5547-1 UPC 8 83484 31020 5   Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912", "product_quantity": "Unknown", "reason_for_recall": "Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.", "recall_initiation_date": "20191120", "center_classification_date": "20200116", "termination_date": "20220928", "report_date": "20200115", "code_info": "Lot: 19277K1"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0176-2022", "product_description": "TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.75MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1007132021:95 BUD: 01/09/2022", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0364-2020", "product_description": "Equate Restore Tears Lubricant Eye Drops Twin Pack  W-M item #: 552374320, Package Size: 2 x 15 mL, Distributed by: Walmart Inc., Bentonville, AR 72716, NDC 49035-189-49", "product_quantity": "557,376 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 17196, Exp 07/19; 17292, Exp 09/19; 17355, Exp 11/19; 19040, Exp 02/21"}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078596"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-178", "65162-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["984302ad-793e-4f35-92da-e5e7f92154f6"], "spl_set_id": ["c01a79e0-f2b7-4d99-857e-bda7f24fe319"], "package_ndc": ["65162-178-89", "65162-178-03", "65162-178-09", "65162-178-10", "65162-178-50", "65162-178-11", "65162-179-03", "65162-179-09", "65162-179-10", "65162-179-50"], "is_original_packager": [true], "upc": ["0365162178104", "0365162179101"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1347-2020", "product_description": "amneal Metformin Hydrochloride Extended-release Tablets, USP, 500 mg Rx only, 100 Tablets bottles, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad 382213 India Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807   NDC 65162-178-10", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "AM181118AA 10/31/2020  AM181191AA 9/30/2020  AM181192AA 9/30/2020  AM181235AA 9/30/2020  AM181236AA 9/30/2020  AM181237AA 9/30/2020  AM181240AA 9/30/2020  AM181241AA 9/30/2020  AM181242AA 9/30/2020  AM181243AA 9/30/2020  AM181244AA 10/31/2020  AM181268AA 10/31/2020  AM181269AA 10/31/2020  AM181270AA 10/30/2020  AM181271AA 10/31/2020  AM181272AA 10/31/2020  AM181273AA 10/31/2020  AM181274AA 10/31/2020  AM181275AA 10/31/2020  AM181276AA 10/31/2020  AM181277AA 10/31/2020  AM181307AA 10/31/2020  AM181308AA 10/31/2020  AM181309AA 10/31/2020  AM181310AA 10/31/2020  AM181311AA 10/31/2020  AM181313AA 10/31/2020  AM181314AA 10/31/2020  AM181315AA 11/30/2020  AM181316AA 11/30/2020  AM181317AA 12/31/2020  AM181419AA 11/30/2020  AM181420AA 11/30/2020  AM181421AA 11/30/2020  AM181422AA 11/30/2020  AM181423AA 11/30/2020  AM181424AA 11/30/2020  AM181425AA 11/30/2020  AM181430BA 12/31/2020  AM181455AA 12/31/2020  AM181456AA 12/31/2020  AM181457AA 12/31/2020  AM181458AA 12/31/2020  AM181459AA 12/31/2020  AM181460AA 12/31/2020  AM181461AA 12/31/2020  AM181462AA 12/31/2020  AM181463AA 12/31/2020  AM181464AA 12/31/2020  AM181465AA 12/31/2020  AM190054AA 12/31/2020  AM190055AA 12/31/2020  AM190057AA 12/31/2020  AM190058AA 12/31/2020  AM190102AA 12/31/2020  AM190103AA 12/31/2020  AM190104AA 12/31/2020  AM190105AA 12/31/2020  AM190106AA 12/31/2020  AM190107AA 12/31/2020  AM190108AA 12/31/2020  AM190120AA 12/31/2020  AM190633AA 5/31/2021  AM190634AA 5/31/2021  AM190635AA 5/31/2021  AM190636AA 5/31/2021  AM190637AA 5/31/2021  AM190638AA 5/31/2021  AM190640AA 5/31/2021  AM190641AA 5/31/2021  AM190642AA 5/31/2021  AM190664AA 5/31/2021  AM190665AA 5/31/2021  AM190666AA 5/31/2021  AM190667AA 5/31/2021  AM190668AA 5/31/2021  AM190669AA 6/30/2021  AM190670AA 6/30/2021  AM190671AA 6/30/2021  AM190672AA 6/30/2021  AM190714AA 6/30/2021  AM190934A 8/31/2021  AM190991A 8/31/2021  AM190992A 8/31/2021  AM190993A 8/31/2021  AM190994A 8/31/2021  AM191040A 9/30/2021  AM191041A 9/30/2021  AM191083A 9/30/2021  AM191084A 9/30/2021  AM191085A 9/30/2021  AM191091A 9/30/2021  AM191092A 9/30/2021  AM191105A 9/30/2021  AM191106A 10/31/2021  AM191107A 10/31/2021  AM191109A 10/31/2021  AM191186A 10/31/2021  AM191187A 10/31/2021  AM191188A 10/31/2021  AM191189A 10/31/2021  AM191190A 10/31/2021  AM191191A 10/31/2021  AM191192A 10/31/2021  AM191193A 10/31/2021  AM191194A 10/31/2021  AM191195A 10/31/2021  AM191244A 10/31/2021  AM191245A 10/31/2021  AM191246A 10/31/2021  AM191247A 10/31/2021  AM191294A 11/30/2021  AM191295A 11/30/2021  AM191296A 11/30/2021  AM191365A 11/30/2021  AM191366A 11/30/2021  AM191367A 11/30/2021  AM191392A 11/30/2021  AM191393A 11/30/2021  AM191394A 11/30/2021  AM191395A 12/31/2021  AM200001A 12/31/2021  AM200002A 12/31/2021  AM200003A 12/31/2021  AM200004A 12/31/2021  AM200005A 12/31/2021  AM200006A 12/31/2021  AM200045A 12/31/2021  AM200046A 12/31/2021  AM200047A 12/31/2021  AM200048A 12/31/2021  AM200049A 12/31/2021  AM200050A 12/31/2021  AM200051A 12/31/2021  AM200052A 12/31/2021  AM200053A 12/31/2021  AM200081A 12/31/2021  AM200082A 12/31/2021  AM200083 12/31/2021  AM200087A 12/31/2021  AM200088A 12/31/2021  AM200089 12/31/2021  AM200090 12/31/2021  AM200091 12/31/2021  AM200100 1/31/2022  AM200101 1/31/2022  AM200102 1/31/2022  AM200138 1/31/2022  AM200139 1/31/2022  AM200140 1/31/2022  AM200141 1/31/2022  AM200142 1/31/2022  AM200143 1/31/2022  AM200144 1/31/2022  AM200193 1/31/2022  AM200194 1/31/2022  AM200195 1/31/2022  AM200196 1/31/2022  AM200197 1/31/2022  AM200198 1/31/2022  AM200199 1/31/2022  AM200200 1/31/2022  AM200202 1/31/2022  AM200203 1/31/2022  AM200204 1/31/2022  AM200205 1/31/2022  AM200206 1/31/2022  AM200207 1/31/2022  AM200208 1/31/2022  AM200209 1/31/2022  AM200210 1/31/2022  AM200211 1/31/2022  AM200284 2/28/2022  AM200285 2/28/2022  AM200287 2/28/2022  AM200288 2/28/2022  AM200289 2/28/2022  AM200290 2/28/2022  AM200291 2/28/2022  AM200292 2/28/2022"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Glutathione 6%/ascorbic 1%/DMSO 6.25%", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1117-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93255", "recalling_firm": "GlaxoSmithKline  Consumer Healthcare Holdings LLC", "address_1": "320 S Broadway", "address_2": "N/A", "postal_code": "63102-2800", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0078-2024", "product_description": "TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Berries flavor, Chewable Tablets, packaged in 265-count bottle, Dist. by: GSK CH, Warren, NJ 07059. NDC: 135-0181-05, UPC 3-0766-3072-14-7", "product_quantity": "N/A", "reason_for_recall": "Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.", "recall_initiation_date": "20221202", "center_classification_date": "20231027", "report_date": "20231108", "code_info": "Lot #: J96X,J96W, Exp. Date 09/30/2027"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65115", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-452-2013", "product_description": "Budesonide Capsules, 3 mg, Enteric Coated, packaged in 30-count capsules unit dose (3 x 10 capsules blister packaged) per box, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV  26505; Packaged and Distributed by: UDL Laboratories, Inc., Rockford, IL  61103, NDC 51079-020-03.", "product_quantity": "1,621 boxes", "reason_for_recall": "Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an out-of-specification (OOS) result for dissolution testing.", "recall_initiation_date": "20130515", "center_classification_date": "20130522", "termination_date": "20150507", "report_date": "20130529", "code_info": "Lot No: 3037382, Exp 09/13"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "66 ml", "code_info": "All lots distributed between November 2014 and May 2015;    03312015@58, 6/29/2015; and 04012015@68, 6/30/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Sodium Tetradecyl Sulfate 5% Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1635-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72594", "recalling_firm": "Walgreens Infusion Services", "address_1": "14220 Northbrook Dr Ste 100B", "address_2": "N/A", "postal_code": "78232-5045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0538-2016", "product_description": "Milrinone 0.375 mcg/kg/min D5W bag a) 365 mL, b) 400 mL c) 430 mL, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045", "product_quantity": "19 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151110", "center_classification_date": "20151230", "termination_date": "20171018", "report_date": "20160106", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-793-2015", "product_description": "Metronidazole Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "11000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Harriman", "address_1": "144 Route 17m Ste 4", "reason_for_recall": "Penicillin Cross Contamination: potentially contaminated with penicillin", "address_2": "", "product_quantity": "unknown", "code_info": "All lots", "center_classification_date": "20151202", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "BI-EST Gels, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Life Science Pharmacy Inc", "recall_number": "D-0497-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71494", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20150608", "postal_code": "10926-3321", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-791-2015", "product_description": "Methylprednisolone Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "340 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82827", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1445-2019", "product_description": "Pramipexole Dihydrochloride Tablets 0.25 mg, 1000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. NDC 68382-197-10", "product_quantity": "3,156 1000-count bottles", "reason_for_recall": "CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.", "recall_initiation_date": "20190506", "center_classification_date": "20190701", "termination_date": "20210916", "report_date": "20190626", "code_info": "Lots: M706803, EXP Jun-19; M713438, EXP Oct-19; M801704, EXP Jan-20; M808306, EXP Jun-20; M812484, EXP Aug-20;  M820264, EXP Dec-20"}, {"status": "Terminated", "city": "Stamford", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73709", "recalling_firm": "Purdue Pharma L.P.", "address_1": "201 Tresser Blvd", "address_2": "N/A", "postal_code": "06901-3435", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Including: FL, LA, MI, MS, NC, NJ, OH and SC.", "recall_number": "D-0810-2016", "product_description": "Intermezzo (zolpidem tartrate) sublingual tablet 1.75 mg, CIV, 30 Ct Cartons, Rx Only.  Dist by Purdue Pharma L.P., Stamford, CT 06901-3431. NDC: 59011-256-30.", "product_quantity": "2172 Cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20160331", "center_classification_date": "20160404", "termination_date": "20170412", "report_date": "20160413", "code_info": "Lot #: 3126431B, Expiry: 09/30/17", "more_code_info": ""}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "25 Cases", "code_info": "Product Code: 6592-S; Lots: 62154 EXP 02/19/2019", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Oral Cleansing & Suctioning System with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse q2, Contains 1 Covered Yankauer and Y-Connector, 2 Untreated Suction Toothbrush packages, 2 Single dose bottles of 0.12% CHG Oral Rinse, 4 Packages Suction Oral Swab with sodium bicarbonate, Perox-A-Mint solution and Mouth Moisturizer, 6 Packages Suction Oral Swab with sodium bicarbonate, Alcohol Free Mouthwash and Mouth Moisturizer, 2 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6592-S UPC 6 18029 82133 1", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0386-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South El Monte", "address_1": "11030 Weaver Ave", "reason_for_recall": "CGMP Deviations: the product was produced with substandard GMP manufacturing processes.", "address_2": "", "product_quantity": "15,190 boxes", "code_info": "Lot #:14122921, Exp.12/30/20119, 15091512, Exp.  9/15/2020, 6032321, Exp. 3/23/2021, 17030921, Exp. 3/09/2022", "center_classification_date": "20180410", "distribution_pattern": "Nationwide within US", "state": "CA", "product_description": "Zhong Hua Jiu (menthol 1%) Patch, Distributed by United Pacific Company, UPC 6 924938 100226, NDC 53614-001-02", "report_date": "20180418", "classification": "Class II", "openfda": {}, "recalling_firm": "United Pacific Co Ltd", "recall_number": "D-0624-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79693", "termination_date": "20190124", "more_code_info": "", "recall_initiation_date": "20180329", "postal_code": "91733-3540", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72028", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1161-2016", "product_description": "LIDocaine HCl 1% BUFFERED WITH SODIUM BICARBONATE Injection, packaged in 3 mL Syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- UPC: 9999992033", "product_quantity": "450 syringes", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20150821", "center_classification_date": "20160706", "termination_date": "20170203", "report_date": "20160713", "code_info": "Lot: 150947, exp 9/5/15; 151087, exp 9/21/15"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "12 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  04032015@53, 6/2/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 5,000 IU/ml + Methylcobalamin 500 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1517-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0993-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10% with CALCIUM and HEPARIN, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0416-1", "product_quantity": "188 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-254909, Exp. 7/22/2023; 36-256333, Exp. 7/29/2023."}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078895"], "brand_name": ["CLONIDINE HYDROCHLORIDE"], "generic_name": ["CLONIDINE HYDROCHLORIDE"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "product_ndc": ["29300-135", "29300-468", "29300-136", "29300-137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONIDINE HYDROCHLORIDE"], "rxcui": ["884173", "884185", "884189"], "spl_id": ["5929c96f-9fa9-4399-84aa-28584da9966a"], "spl_set_id": ["21bfa28f-20df-43fd-bb80-b720d3b40696"], "package_ndc": ["29300-468-05", "29300-468-10", "29300-468-50", "29300-468-01", "29300-136-01", "29300-136-05", "29300-136-10", "29300-136-50", "29300-137-01", "29300-137-05", "29300-137-10", "29300-137-25", "29300-135-01", "29300-135-05", "29300-135-10", "29300-135-50"], "is_original_packager": [true], "upc": ["0329300136012", "0329300135015", "0329300468014", "0329300137019"], "unii": ["W76I6XXF06"]}, "product_type": "Drugs", "event_id": "90709", "recalling_firm": "UNICHEM PHARMACEUTICALS USA INC", "address_1": "1 Tower Center Blvd Ste 2200", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1541-2022", "product_description": "Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC. East Brunswick, NJ 08816. NDC# 29300-137-01", "product_quantity": "18,960 bottles of 100", "reason_for_recall": "Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,", "recall_initiation_date": "20220919", "center_classification_date": "20220922", "termination_date": "20230302", "report_date": "20220928", "code_info": "Lot # GCLH22005, exp. date 02/29/2024"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-801-2015", "product_description": "Mirtazapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "4181 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090034"], "brand_name": ["RIFAMPIN"], "generic_name": ["RIFAMPIN"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-658", "68180-659"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIFAMPIN"], "rxcui": ["198201", "198202"], "spl_id": ["3c9f0101-dcf8-487e-985e-09c56746d3a1"], "spl_set_id": ["b56004f0-f23d-47f6-80c7-39884fccbccc"], "package_ndc": ["68180-658-06", "68180-658-01", "68180-659-06", "68180-659-07", "68180-659-01"], "is_original_packager": [true], "nui": ["N0000175500", "M0019113"], "pharm_class_epc": ["Rifamycin Antibacterial [EPC]"], "pharm_class_cs": ["Rifamycins [CS]"], "unii": ["VJT6J7R4TR"]}, "product_type": "Drugs", "event_id": "91295", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0100-2023", "product_description": "Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06", "product_quantity": "16,056 30 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.", "recall_initiation_date": "20221212", "center_classification_date": "20230109", "termination_date": "20240131", "report_date": "20230118", "code_info": "Lot # A200171, Exp 12/2023", "more_code_info": ""}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "64835", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-258-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles ( NDC 60793-857-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.", "product_quantity": "7901 bottles", "reason_for_recall": "Chemical contamination: emission of strong odor after package was opened.", "recall_initiation_date": "20130328", "center_classification_date": "20130418", "report_date": "20130424", "code_info": "Lot # a)  67013B, Exp. 01/14; b) 66900B, Exp. 01/14"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0733-2021", "product_description": "Amikacin Sulfate Injection USP 1 gram/4mL (250mg/ML), 4 mL single-dose vials, Rx only, Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0703-9040-01", "product_quantity": "4,712 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 31329243B, exp. date 05/2022"}, {"status": "Ongoing", "city": "Tonala", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86898", "recalling_firm": "GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION", "address_1": "Castilla 1473a Coloniajardines De", "address_2": "Tonala", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0229-2021", "product_description": "Pristine gel Hand Sanitizer Gel Antibacterial Gel Moisturizing, 8.45 Fl. Oz. (250 mL) Bottle, Distributed by: Universal Distributors LLC, 6197 S. Rural Rd.,Tempe AZ, 85283, Made in Mexico by: Gaza Proveedora De Servicios De Hospedaje y Alimentos S.A. de C.V., UPC 8 64972 00049 5, NDC 76540-100-02", "product_quantity": "26,000 liters", "reason_for_recall": "cGMP deviations: Product made at the same facility where product tested was sub-potent.", "recall_initiation_date": "20201201", "center_classification_date": "20210114", "report_date": "20210120", "code_info": "All Lots"}, {"status": "Terminated", "city": "South Plainfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074089"], "brand_name": ["CLOBETASOL PROPIONATE"], "generic_name": ["CLOBETASOL PROPIONATE"], "manufacturer_name": ["Cosette Pharmaceuticals, Inc."], "product_ndc": ["0713-0656"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["CLOBETASOL PROPIONATE"], "rxcui": ["861448"], "spl_id": ["0b383db5-a99b-f222-e063-6294a90adc09"], "spl_set_id": ["807d6a1a-4eca-9cf4-f514-bb1cd7b10d0f"], "package_ndc": ["0713-0656-15", "0713-0656-31", "0713-0656-37", "0713-0656-60"], "is_original_packager": [true], "upc": ["0307130656313"], "unii": ["779619577M"]}, "product_type": "Drugs", "event_id": "77401", "recalling_firm": "G & W  Laboratories, Inc.", "address_1": "111 Coolidge St", "address_2": "N/A", "postal_code": "07080-3895", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0945-2017", "product_description": "G & W Clobetasol Propionate Ointment 0.05%, packaged in a) 15 g tube (NDC 0713-0656-15), b) 30 g tube (NDC 0713-0656-31, c) 45 g tube (NDC 0713-0656-37), d) 60 g tube (NDC 0713-0656-60), Rx Only, Manufactured by G & W Laboratories, Inc. 111 Coolidge Street, South Plainfield, NJ 07080", "product_quantity": "145284 tubes", "reason_for_recall": "Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.", "recall_initiation_date": "20170602", "center_classification_date": "20170706", "termination_date": "20180509", "report_date": "20170712", "code_info": "Lot #: a) 1001090, Exp 8/ 17; 1002881, Exp 2/18; b) 1001086, Exp 8/ 17; 1001154, Exp 11/ 17; 1001156, Exp 9/17; 1002882, Exp 2/18, 1004564, Exp 7/18; c) 1001155, Exp 9/17; 1004572, Exp 7/18; d) 1001158, Exp 9/17; 1001159, Exp 10/17; 1002884, Exp 4/18"}, {"status": "Ongoing", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125320"], "brand_name": ["PROLIA"], "generic_name": ["DENOSUMAB"], "manufacturer_name": ["Amgen, Inc"], "product_ndc": ["55513-710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["DENOSUMAB"], "rxcui": ["993452", "993456"], "spl_id": ["f5a330b4-e272-4aa1-9fce-afdfce5543aa"], "spl_set_id": ["49e5afe9-a0c7-40c4-af9f-f287a80c5c88"], "package_ndc": ["55513-710-01", "55513-710-21"], "is_original_packager": [true], "nui": ["N0000187055", "N0000187054"], "pharm_class_epc": ["RANK Ligand Inhibitor [EPC]"], "pharm_class_moa": ["RANK Ligand Blocking Activity [MoA]"], "unii": ["4EQZ6YO2HI"]}, "product_type": "Drugs", "event_id": "97110", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within the U.S - OH, VA, FL.", "recall_number": "D-0538-2025", "product_description": "PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21", "product_quantity": "6 Pre-filled syringes", "reason_for_recall": "CGMP Deviations; potential temperature excursions due to transit delays", "recall_initiation_date": "20250421", "center_classification_date": "20250721", "report_date": "20250730", "code_info": "Lot: 1180924, Expiration date: 6/30/2027."}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "HARD TEN DAYS capsules, 4500mg, 6-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class II", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0557-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "38 mL total volume", "code_info": "All lots distributed between November 2014 and May 2015;  04232015@35, 7/22/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Cyanocobalamin 1,000 mcg/ml + B-Complex 100 mg/ml, ml, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1459-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA020725"], "brand_name": ["CREON"], "generic_name": ["PANCRELIPASE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0032-0045", "0032-1203", "0032-1206", "0032-1212", "0032-1224", "0032-3016", "0032-0046", "0032-0047", "0032-2636", "0032-2637"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PANCRELIPASE AMYLASE", "PANCRELIPASE LIPASE", "PANCRELIPASE PROTEASE"], "rxcui": ["855495", "855499", "855503", "863829", "863836", "863841", "1113042", "1113046", "1373325", "1373327"], "spl_id": ["94463229-9296-4640-854f-41d76386d312"], "spl_set_id": ["073201aa-556d-4a70-918e-84e9616fd88d"], "package_ndc": ["0032-1203-70", "0032-1203-64", "0032-1206-07", "0032-1206-01", "0032-1206-56", "0032-1212-07", "0032-1212-01", "0032-1212-46", "0032-1212-13", "0032-1224-07", "0032-1224-01", "0032-1224-46", "0032-3016-28", "0032-3016-13", "0032-3016-50", "0032-3016-12", "0032-0045-70", "0032-0045-30", "0032-0046-30", "0032-0046-70", "0032-0047-30", "0032-0047-70", "0032-2636-70", "0032-2636-01", "0032-2636-30", "0032-2637-70", "0032-2637-01", "0032-2637-30"], "is_original_packager": [true], "upc": ["0300322637701", "0300320045706", "0300320047700", "0300320046703", "0300323016130", "0300322636704", "0300321224018"], "unii": ["3560D81V50", "YOJ58O116E", "8MYC33932O"]}, "product_type": "Drugs", "event_id": "69285", "recalling_firm": "AbbVie Inc", "address_1": "1 N Waukegan Rd", "address_2": "N/A", "postal_code": "60064", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide", "recall_number": "D-1611-2014", "product_description": "CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.", "product_quantity": "18,021 Bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.", "recall_initiation_date": "20140915", "center_classification_date": "20140926", "termination_date": "20160622", "report_date": "20141008", "code_info": "Lot #: 1020156; Expiry: 3/31/2016"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1618-2019", "product_description": "Thyro-H, 500 mg Capsules, 90-count bottles, Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}]